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Abstract Recently, p73 was identi¢ed as a structural and func-
tional homolog of p53. The p73 protein activates the transcrip-
tion of genes downstream of p53 and induces apoptosis when
overexpressed in several cell lines, similar to the tumor suppres-
sor p53. However, the extracellular stimuli and molecular mech-
anisms regulating p73 activity remain to be elucidated. In this
paper, we present evidence that the naphthoquinone analog,
2,3-dichloro-5,8-dihydroxy-1,4-naphthoquinone (NA), is a novel
apoptotic stimulus that induces p73L expression. Treatment with
NA induced the expression of p73L mRNA and protein and its
downstream genes, p21 and bax, in HeLa cells. Similar results
were obtained in MCF7 cells (p53+/+, p73+/+). In the MCF7
cells, p53 protein level was rather decreased by NA treatment.
Overexpression of p73L led to the apoptosis of HeLa cells and
enhancement of NA-induced cell death. Expression of p73L was
mediated by E2F-1, which was activated via release from pRB
after exposure of cells to NA. We additionally observed that
overexpression of pRB inhibited NA-induced apoptosis. These
results imply that p53-independent p73L-dependent p21 expres-
sion is involved in NA-induced apoptosis of HeLa cells. 6 2002
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1. Introduction
Apoptosis is an important regulatory mechanism that elim-
inates unwanted cells during the development and mainte-
nance of cell homeostasis. In many cases, the apoptotic pro-
cess requires the p53 tumor suppressor protein. Several
stimuli, such as DNA-damaging agents, withdrawal of growth
factors and expression of myc or E1A, also cause p53-depen-
dent apoptosis [1^4]. The cellular role of p53 is achieved pri-
marily through its ability to transcriptionally activate speci¢c
target genes [5], including the cell cycle regulatory gene, p21
[6], and the apoptosis-regulating gene, bax [7]. Thus, the tran-
scriptional activity of p53 is critical in p53-mediated cell
growth and apoptosis. However, the integrity or activity of
p53 is impaired in most malignant tumors. Although p53-de-
¢cient cancer cells are less responsive to chemotherapy, resis-
tance is not complete, since a proportion of the malignant
cells still undergo apoptosis. This p53-independent apoptosis
is often accompanied by p21 induction, suggesting the in-
volvement of another tumor suppressor protein [8^10].
Recently, p73 was identi¢ed as a p53 homolog [11]. At least
four splicing variants of p73 expressed in a tissue-speci¢c
manner are recognized, speci¢cally, p73K, p73L, p73Q and
p73N [12]. The signi¢cant sequence homology between p73
and p53 suggests that the two proteins perform similar func-
tions [13,14]. Ectopic expression of p73 not only activates the
transcription of p53 target genes, but also induces apoptosis
and growth suppression in cells, irrespective of their p53 sta-
tus [11,14,15]. However, a number of di¡erences between p73
and p53 have been reported. p73 di¡erentially transactivates
only certain, not all p53-responsive genes [16,17]. The steady-
state levels of p73 are not reduced by complex formation with
MDM2 [18,19] that induces the ubiquitination and proteolytic
degradation of p53 [20^22]. In addition, viral oncoproteins,
including adenovirus E1B, SV40 large T antigen and human
papilloma E6 that bind wild-type p53 and inhibit activity, do
not interact with p73 [23^25]. Furthermore, the levels of p73
are not a¡ected by exposure to DNA-damaging agents (such
as actinomycin D or UV irradiation) that increase p53 levels,
indicating that the two proteins have distinct cellular func-
tions. An earlier study demonstrated that p73 is involved in
cellular response to DNA damage induced by Q-irradiation
and chemotherapeutic agents such as cisplatin [26]. However,
the extracellular stimuli capable of inducing p73 are yet to be
identi¢ed.
Menadione (known as vitamin K3) is currently a focus of
research interest, since it displays a broad range of antitumor
activity in human cells and imposes lower levels of toxicity
than other cancer chemotherapeutic drugs with a quinone
structure, such as doxorubicin, daunorubicin and mitomycin
C. Menadione inhibits cell growth via a cell cycle progression
delay (S/G2), alters phosphorylation and activates both
p34cdc2 kinase and protein tyrosine phosphatase [27]. A thio-
ether analog of menadione that inhibits cell growth exerts its
e¡ects via sulfhydryl arylation of cellular PTPase [28]. In ad-
dition, menadione induces G1 arrest by generating superoxide
in several cell lines [28]. However, since the hydrophobic na-
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ture of menadione may generate physicochemical changes in
the cell membrane leading to cytotoxicity, several vitamin K3
analogs were recently synthesized. Of these, 2,3-dichloro-5,8-
dihydroxy-1,4-naphthoquinone (NA) was identi¢ed as the
most potent growth inhibitor and apoptotic inducer. NA in-
duces G1 arrest through cdc25A phosphatase inhibition in
hepatocarcinoma cells [29]. Recently, it was reported that
NA not only triggers apoptosis but also restores the tolerance
to apoptosis mediated by tumor necrosis factor-K in HeLa
cells. We also showed that NA induced the cleavage of p65
(a component of nuclear factor-UB) at the NH2-terminus via
the activation of caspase-3 [30]. We examined the mechanism
of NA-mediated cell death under the assumption that p73L is
involved in apoptosis of HeLa cells. Our data reveal that p73L
is generated at the transcriptional level during NA-induced
apoptosis. Expression of p21 and Bax is additionally induced
in a p73L-dependent manner. p73L overexpression accelerates
NA-induced apoptosis. In addition, induction of the p73L
protein is mediated by E2F-1, which is activated through
release from pRB (a negative regulator of E2F-1) during
NA-induced apoptosis.
2. Materials and methods
2.1. Cell culture, reagents and vector constructs
HeLa cells were maintained in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml
penicillin and 100 Wg/ml streptomycin at 37‡C. All reagents used for
cell culture were purchased from Gibco BRL (USA). The pcDNA3-
HA-p73L construct was generously provided by Dr. Daniel Cauput
(Sano¢ Recherche, France). From pcDNA3-HA-p73L, GFP-73L was
constructed by subcloning into the BamHI/XbaI restriction sites of
pEGFP-C1.
2.2. Cell viability, apoptotic cells and FACS analysis
Cell viability was determined by the trypan blue exclusion method
at di¡erent time points. For analysis of apoptosis, HeLa cells were
transfected with pEGFP-C1-p73L or pEGFP-C1. After 48 h of trans-
fection, cells were observed under a Nikon £uorescence microscope.
Apoptotic cells were identi¢ed by their rounded morphology, in con-
trast to the spread-out morphology of non-apoptotic cells. Apoptotic
cell numbers were counted and are presented as a percentage of the
total population of cells expressing green £uorescent protein (GFP).
The apoptosis of GFP-expressing cells was additionally measured by
£uorescence activated cell sorting (FACS) analysis. Cells were trypsi-
nized, washed with phosphate-bu¡ered saline (PBS) and ¢xed in 70%
ethanol. Fixed cells were re-washed with PBS, incubated with 1 Wg/ml
RNase for 30 min and stained with 100 Wg/ml propidium iodide (Sig-
ma). Stained cells were analyzed on a FACScan £ow cytometer (Bec-
ton Dickinson) for calculation of the relative DNA content. The dou-
ble £uorescence-expressing cells were analyzed for apoptosis.
2.3. DNA fragmentation
Cells were lysed in 400 Wl lysis bu¡er (10 mM Tris^HCl pH 8.0, 100
mM NaCl, 25 mM EDTA pH 8.0, 0.5% sodium dodecyl sulfate
(SDS), 0.1 mg/ml proteinase K), and incubated at 50‡C for 15 h.
Genomic DNA was prepared by phenol/chloroform extraction and
precipitated with absolute ethanol. After treatment with RNase A
(0.1 mg/ml) for 2 h, the DNA sample was separated by electrophoresis
on a 1.5% agarose gel and visualized under UV with ethidium bro-
mide.
2.4. Northern blot analysis
Total RNA was extracted from cells as described previously. RNA
(30 Wg) was separated on 1% formaldehyde agarose gels, transferred
onto nitrocellulose membranes (Hoefer, USA) and hybridized to hu-
man p73L cDNA probes labeled with [32P]dCTP by the random prim-
er method, using the manufacturer’s instructions (Boehringer Mann-
heim, Germany). The membrane was hybridized for 24 h at 42‡C in a
solution of 50% deionized formamide, 5Usaline sodium citrate (SSC),
5UDenhardt’s solution, 0.5% SDS and 200 Wg/ml salmon sperm
DNA, and washed twice with 2USSC and 0.1% SDS at 42‡C.
2.5. Immunoprecipitation and Western blot analysis
Cells were lysed in TNN bu¡er (50 mM Tris^HCl pH 7.5, 150 mM
NaCl, 1% Nonidet P-40 and 1 mM phenylmethylsulfonyl £uoride).
Total cell lysates (100 Wg) were subjected to SDS^polyacrylamide gel
electrophoresis and electrophoretically transferred to polyvinylidene
di£uoride membranes. Membranes were blocked with Tris-bu¡ered
saline comprising 0.5% Tween-20 (TBST) with 5% skimmed milk,
and incubated with primary antibodies, polyclonal antibody against
p73L generated from GST-p73L, monoclonal antibody against p53
(Santa Cruz, sc-126), polyclonal antibody against p21 (Santa Cruz,
sc-397), polyclonal antibody against Bax (Santa Cruz, sc-439), and
monoclonal antibody against GFP (Roche, 1814 460). Next, mem-
branes were washed with TBST and treated with secondary antibody
conjugated to peroxidase. Protein was detected with an enhanced
chemiluminescence (ECL) assay using Amersham ECL reagents, fol-
lowed by exposure to ¢lm. For immunoprecipitation, 400 Wg total
protein was pre-cleaned with 30 Wl protein A agarose beads, and in-
cubated on ice for 3 h with fresh protein A beads in the presence of
1 Wg polyclonal antibody against pRB (Santa Cruz, sc-050). Immuno-
precipitates were washed three times with TNN bu¡er and subjected
to SDS^polyacrylamide gel electrophoresis. The amount of E2F-1
bound to pRB was determined by Western blot analysis, using a
polyclonal antibody against E2F-1 (Santa Cruz, sc-192).
3. Results
3.1. p73L is transcriptionally activated during
NA-induced apoptosis in HeLa cells
To establish whether NA induces apoptosis, HeLa cells
were treated with 15 WM NA for the indicated time periods,
and cell viability was examined with trypan blue dye exclu-
sion. Six hours after treatment with NA, cell viability was
diminished by 50%, and most of the cells underwent apoptosis
within 24 h (Fig. 1A). Apoptosis by NA was con¢rmed by
DNA fragmentation, which was detected faintly at 12 h and
strongly at 24 h. DNA fragmentation was also observed in
preparations treated with 10 WM NA for 24 h, which in-
creased in a concentration-dependent manner (Fig. 1B). Pro-
teolytic cleavage of poly(ADP ribose) polymerase (PARP) by
caspase is a predominant biochemical hallmark of apoptosis.
PARP cleavage by NA during the course of apoptosis was
examined. Within 24 h of NA treatment, cleavage of PARP
into a 89 kDa fragment was observed (Fig. 1C). PARP pro-
tein was not detected at 48 h, indicating that most of the
protein was proteolytically degraded at this stage. Our results
con¢rm that NA induces the apoptosis of HeLa cells.
To investigate whether p73L is involved in NA-induced ap-
optosis, protein levels in HeLa cells were measured after ex-
posure to NA. As shown in Fig. 2A, p73L expression began to
increase at 12 h after treatment with 15 WM NA in a time-
dependent manner. p73L was induced by 10 WM NA and
reached maximum levels with 15 WM. An increase in mRNA
levels of p73L was additionally noted, indicating that p73L is
transcriptionally induced by NA in HeLa cells (Fig. 2B).
The transcription factor p73L stimulates the expression of
several genes, including the cyclin-dependent kinase inhibitor,
p21, and the proapoptotic factor, bax. To determine whether
p73L induced by NA possesses transcriptional activity, the
expression of the two downstream genes, p21 and bax, was
examined. Protein levels of p21 and Bax increased in concur-
rence with that of p73L. Northern blot analyses revealed an
increase in the mRNA levels of p21 and bax (Fig. 2B). Be-
cause p53 protein is inactivated by human papilloma virus 18
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in HeLa cell, we can rule out the possibility that the induction
of p21 and bax may be due to the p53. In order to con¢rm
that NA induced p21 and bax through a p73-dependent, p53-
independent pathway, we performed the same set of experi-
ments in human breast carcinoma MCF7 cells, in which both
p53 and p73 are wild type. As shown in Fig. 3A, the amount
of p73 protein increased signi¢cantly after treatment with NA.
Levels of both bax and p21 increased, although the incre-
ments were not as great as for p73. In contrast to p73, p53
protein levels did not increase, but rather decreased in a time-
dependent manner, and disappeared at 48 h after NA treat-
ment (Fig. 3A). mRNA level was also examined and the re-
sults were similar to that of HeLa cells (Fig. 3B). These results
indicate that the expression of p21 and bax induced by NA is
not mediated by p53, but p73L. Therefore, we suggest that
p73L participates in NA-induced apoptosis through its tran-
scriptional function.
3.2. Overexpression of p73L accelerates NA-induced apoptosis
To determine whether p73L acts as a positive regulator of
Fig. 1. NA induces apoptosis in HeLa cells. A: HeLa cells were treated with 15 WM NA, and cell viability was determined by trypan blue ex-
clusion at the indicated time points. B: Internucleosomal DNA fragmentation was investigated in a time- and dose-dependent manner. Cells
were treated with 0^20 WM NA for 24 h (left panel) or 15 WM NA for the indicated time periods (right panel). Total genomic DNA was pre-
pared, separated on a 1.5% agarose gel and visualized by ethidium bromide staining. C: Cleavage of PARP after treatment with NA was moni-
tored by Western blot analysis using a monoclonal antibody against the C-terminus of PARP.
Fig. 2. Expression of p73L and its downstream genes is increased during NA-induced apoptosis in HeLa cells. A: Protein levels of p73L, p21
and Bax were examined by Western blot analysis at the indicated time points after treatment with 15 WM NA or at 24 h after treatment with
various doses of NA. B: The mRNA levels of p73L, p21 and Bax were examined by Northern blotting at 24 h.
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Fig. 3. Expression of p73L and its downstream genes is increased during NA-induced apoptosis in MCF7 cells. A: Protein levels of p73L, p21,
Bax and p53 were examined by Western blot analysis at the indicated time points after treatment with 15 WM NA or at 24 h after treatment
with various doses of NA. B: Northern blot analyses of p73L, p21 and Bax were performed as a parallel set.
Fig. 4. Overexpression of p73L accelerates NA-induced apoptosis. A: HeLa cells expressing GFP or GFP-p73L were ¢xed at 48 h post-transfec-
tion, stained with propidium iodide and analyzed by FACS. GFP-expressing cells were gated using an arbitrary line (R1), and the DNA con-
tent of the sub-G1 fraction was analyzed in cells. B: After transfection of GFP or GFP-p73L into HeLa, cells were treated with NA for 24 h.
Apoptosis was determined by the rounded-up morphology of GFP-positive cells under a £uorescence microscope. C: Transfection of p73L was
monitored by Western blot analysis using a monoclonal antibody against GFP. Cleavage of PARP in cells treated with NA was also examined
by Western blotting.
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NA-induced apoptosis, HeLa cells were transiently transfected
with an expression plasmid encoding GFP-tagged human
p73L. We examined these GFP-positive cells under a £uores-
cence microscope without ¢xation to assess the rate of apo-
ptosis in transfected cells. As shown in Fig. 4A (upper panel),
GFP-p73L was localized at the nucleus. The nuclei of cells
expressing GFP-p73L were apoptotically fragmented. A large
number of cells expressing p73L underwent apoptosis, as re-
£ected by the rounding and shrinkage morphology of dying
cells. When GFP-p73L-transfected cells were monitored by
FACS, over 30% of cells were observed in the sub-G1 phase
(Fig. 4A, lower panel). These results indicate that an increase
in p73L, which induces downstream gene expression, is su⁄-
cient to trigger the apoptosis of HeLa cells.
We examined whether p73L contributes to cell death in-
duced by NA (Fig. 4B). HeLa cells were transfected with
GFP-p73L for 36 h and incubated in the absence or presence
of NA for 12 h. Apoptosis was determined by counting of
rounded or cleaved cells among the cells expressing GFP. The
death of GFP-expressing cells was monitored by FACS anal-
ysis. As illustrated in Fig. 4B, NA-induced apoptosis was
substantially accelerated in cells containing p73L. This apo-
ptosis was con¢rmed by the cleavage pattern of PARP (Fig.
4C). Our results demonstrate that functionally active p73L
plays a key role as a positive regulator during NA-induced
apoptosis.
3.3. p73L induction is mediated by E2F-1 during
NA-induced apoptosis
We investigated the molecular mechanism of p73L induc-
tion during NA-stimulated apoptosis. Two distinct mecha-
nisms activating p73 have been demonstrated so far, speci¢-
cally via c-abl-dependent tyrosine phosphorylation after
exposure of cells to Q-irradiation or by transcription factor
E2F-1 following T cell receptor hypermethylation. Our data
showed that p73L was transcriptionally induced upon treat-
ment with NA. Therefore, the possibility that E2F-1 is respon-
sible for p73L expression during NA-stimulated apoptosis was
examined. We measured E2F-1 protein levels after exposure
of HeLa cells to NA. The amount of E2F-1 protein in cells
was not a¡ected by NA (Fig. 5A).
E2F-1 activity is modulated by the negative regulator, pRB.
In normal conditions, E2F-1 is sequestered into an inactive
form by pRB. After stimulation, pRB is phosphorylated by
cdks, following which E2F-1 is activated by release from pRB.
Accordingly, we examined whether E2F-1 was activated by
release from pRB, following treatment with NA. Total cell
extracts were subjected to immunoprecipitation with pRB
antibody, and immunoprecipitates were immunoblotted with
E2F-1 antibody. The amount of E2F-1 that bound to pRB
was signi¢cantly reduced in the presence of NA (Fig. 5A,
middle panel). Thus, it is possible that E2F-1 activated by
release from pRB induces p73L expression during NA-induced
apoptosis. To con¢rm that E2F-1 triggers endogenous p73L
expression, HeLa cells were transfected with this transcription
factor and p73L protein levels were examined. Levels of p73L
were augmented by the ectopic expression of E2F-1 (Fig. 5B).
Examination of p73L protein levels after transfection with
pRB revealed that expression was maintained at a basal level.
Our results indicate that p73L induced by NA is mediated by
E2F-1 at the transcriptional level.
We additionally investigated the e¡ects of pRB on NA-in-
Fig. 5. p73L expression is mediated by E2F-1 during NA-induced apoptosis. A: Expression of E2F-1 was examined by Western blot analysis
after treatment with NA (upper panel). Total cell lysates (200 Wg) were immunoprecipitated with pRB antibody and the amount of E2F-1
bound to pRB was examined by Western blotting using E2F-1 antibody (middle panel). The same blot was reprobed with an antibody against
pRB (lower panel). B: HeLa cells were transfected with E2F-1- or pRB-expressing vector for 48 h, and levels of p73L were monitored by West-
ern blotting. C: Cells were co-transfected with pRB and the GFP-expressing vector. After 48 h, cells were treated with 15 WM NA for 12 h,
and apoptosis was determined by observing morphological changes in GFP-expressing cells under a £uorescence microscope.
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duced apoptosis in HeLa cells. Overexpression of pRB re-
sulted in a decrease in apoptosis, indicating that the protein
protects cells from p73L-mediated death. Expression of pRB
alone did not a¡ect cell death (Fig. 5C). Together with the
data discussed above, these results suggest that p73L is tran-
scriptionally induced by E2F-1 and functions as a positive
regulator of apoptosis via the induction of downstream gene
expression during NA-stimulated cell death.
4. Discussion
p73 is a member of the p53 tumor suppressor protein fam-
ily, which is implicated in development, cellular di¡erentia-
tion, apoptosis and tumor suppression [31]. However, the
type of stimuli inducing p73 and the mechanism of regulation
of activity are yet to be identi¢ed. In this study, we demon-
strate that p73L is induced during NA-caused apoptosis of
HeLa cells. In turn, p73L mediates in NA-induced apoptosis
by transactivating the downstream genes, p21 and bax. Fur-
thermore, p73L induction is mediated by the transcription
factor, E2F-1. Overexpression of pRB (a negative regulator
of E2F-1) inhibits p73L-induced apoptosis.
Numerous studies show data con¢rming p53-independent
apoptosis, which is sometimes accomplished with p21 induc-
tion [8^10]. Since p73 is a structural and functional homolog
of p53, the former protein may replace the latter as a tumor
suppressor. However, accumulating data report that the func-
tions of these two proteins are not fully interchangeable, since
p73 is not induced by various apoptotic stimuli activating p53
[26,32,33]. We observed p53-independent p21 induction dur-
ing NA-induced apoptosis in breast carcinoma, HeLa cells,
and hepatocarcinoma (data not shown). The molecular mech-
anism of p53-independent p21 expression during NA-induced
apoptosis remains to be clari¢ed. In this study, we examined
the possibility that p73L is responsible for p53-independent
p21 induction and apoptosis by NA in HeLa cells as well
as MCF7 cells. Our results con¢rm that p73L is one of the
factors involved in NA-stimulated apoptosis, although the
induction of this protein alone is evidently not su⁄cient to
entirely account for the apoptotic e¡ects of NA. Previously,
we reported that ceramide-induced apoptosis was accompa-
nied by p53-independent p21 induction and that conversely,
p21 potentiated ceramide-induced apoptosis in human hepa-
tocarcinoma cells [34,35]. However, ceramide does not induce
p73L expression (data not shown). Therefore, although p53
may be substituted by p73 in our system, it is evident that
all p53-independent p21 induction mechanisms do not involve
p73.
Despite the structural similarities between p73L and p53,
the former protein was not activated by many p53-inducing
stimuli. Several stimuli have been shown to induce p73. Cis-
platin and Q-irradiation activate p73 via a post-transcription
mechanism [26] and through c-abl-mediated tyrosine phos-
phorylation, respectively [32,33]. A number of recent studies
reveal that p73 is induced by E2F-1 and contributes to the
apoptotic e¡ects of this transcription factor [36,37]. Moreover,
p73 was reported to be induced by oncogenes, which were also
mediated by E2F-1 [38]. Data from this study show that p73L
is induced through E2F-1, which is activated upon release
from pRB during NA-induced apoptosis. We tested the pos-
sibility of tyrosine phosphorylation of p73L during apoptosis.
However, p73L phosphorylation was not detected in our sys-
tem, indicating that the c-abl activation pathway is not in-
volved in p73L induction during NA-induced cell death. p73
has several splicing variants, which have di¡erent e¡ects on
apoptosis. Since only p73L was investigated, we cannot ex-
clude the possibility that other splicing variants are addition-
ally involved in apoptosis triggered by NA.
In summary, p73L is induced through the E2F-1 pathway,
which in turn transactivates the downstream genes, p21 and
bax, during NA-induced apoptosis. Based on these results, we
suggest that NA is one of the apoptotic stimuli that induce
p73 along with cisplatin and Q-irradiation.
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